212 related articles for article (PubMed ID: 20574003)
1. CXCL13 blockade disrupts B lymphocyte organization in tertiary lymphoid structures without altering B cell receptor bias or preventing diabetes in nonobese diabetic mice.
Henry RA; Kendall PL
J Immunol; 2010 Aug; 185(3):1460-5. PubMed ID: 20574003
[TBL] [Abstract][Full Text] [Related]
2. Evolution of ectopic lymphoid neogenesis and in situ autoantibody production in autoimmune nonobese diabetic mice: cellular and molecular characterization of tertiary lymphoid structures in pancreatic islets.
Astorri E; Bombardieri M; Gabba S; Peakman M; Pozzilli P; Pitzalis C
J Immunol; 2010 Sep; 185(6):3359-68. PubMed ID: 20713891
[TBL] [Abstract][Full Text] [Related]
3. Dysregulated B7-1 and B7-2 expression on nonobese diabetic mouse B cells is associated with increased T cell costimulation and the development of insulitis.
Hussain S; Delovitch TL
J Immunol; 2005 Jan; 174(2):680-7. PubMed ID: 15634886
[TBL] [Abstract][Full Text] [Related]
4. Identification and characterisation of tertiary lymphoid organs in human type 1 diabetes.
Korpos É; Kadri N; Loismann S; Findeisen CR; Arfuso F; Burke GW; Richardson SJ; Morgan NG; Bogdani M; Pugliese A; Sorokin L
Diabetologia; 2021 Jul; 64(7):1626-1641. PubMed ID: 33912981
[TBL] [Abstract][Full Text] [Related]
5. Mucosa-associated (beta 7-integrinhigh) lymphocytes accumulate early in the pancreas of NOD mice and show aberrant recirculation behavior.
Hänninen A; Salmi M; Simell O; Jalkanen S
Diabetes; 1996 Sep; 45(9):1173-80. PubMed ID: 8772718
[TBL] [Abstract][Full Text] [Related]
6. Lymphocyte subsets in thymus and peripheral lymphoid tissues of aging and diabetic NOD mice.
Zhang ZL; Constantinou D; Mandel TE; Georgiou HM
Autoimmunity; 1994; 17(1):41-8. PubMed ID: 8025213
[TBL] [Abstract][Full Text] [Related]
7. IL-12 administration accelerates autoimmune diabetes in both wild-type and IFN-gamma-deficient nonobese diabetic mice, revealing pathogenic and protective effects of IL-12-induced IFN-gamma.
Trembleau S; Penna G; Gregori S; Giarratana N; Adorini L
J Immunol; 2003 Jun; 170(11):5491-501. PubMed ID: 12759426
[TBL] [Abstract][Full Text] [Related]
8. Tertiary lymphoid structures in the pancreas promote selection of B lymphocytes in autoimmune diabetes.
Kendall PL; Yu G; Woodward EJ; Thomas JW
J Immunol; 2007 May; 178(9):5643-51. PubMed ID: 17442947
[TBL] [Abstract][Full Text] [Related]
9. B-Lymphocyte Phenotype Determines T-Lymphocyte Subset Differentiation in Autoimmune Diabetes.
Egia-Mendikute L; Arpa B; Rosell-Mases E; Corral-Pujol M; Carrascal J; Carrillo J; Mora C; Chapman H; Panosa A; Vives-Pi M; Stratmann T; Serreze D; Verdaguer J
Front Immunol; 2019; 10():1732. PubMed ID: 31428087
[TBL] [Abstract][Full Text] [Related]
10. Peripherin is a relevant neuroendocrine autoantigen recognized by islet-infiltrating B lymphocytes.
Puertas MC; Carrillo J; Pastor X; Ampudia RM; Planas R; Alba A; Bruno R; Pujol-Borrell R; Estanyol JM; Vives-Pi M; Verdaguer J
J Immunol; 2007 May; 178(10):6533-9. PubMed ID: 17475883
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of CC chemokines and the CCR5 receptor in the pancreas is associated with progression to type I diabetes.
Cameron MJ; Arreaza GA; Grattan M; Meagher C; Sharif S; Burdick MD; Strieter RM; Cook DN; Delovitch TL
J Immunol; 2000 Jul; 165(2):1102-10. PubMed ID: 10878389
[TBL] [Abstract][Full Text] [Related]
12. Pancreas-infiltrating Th1 cells and diabetes develop in IL-12-deficient nonobese diabetic mice.
Trembleau S; Penna G; Gregori S; Chapman HD; Serreze DV; Magram J; Adorini L
J Immunol; 1999 Sep; 163(5):2960-8. PubMed ID: 10453045
[TBL] [Abstract][Full Text] [Related]
13. NK T cell-induced protection against diabetes in V alpha 14-J alpha 281 transgenic nonobese diabetic mice is associated with a Th2 shift circumscribed regionally to the islets and functionally to islet autoantigen.
Laloux V; Beaudoin L; Jeske D; Carnaud C; Lehuen A
J Immunol; 2001 Mar; 166(6):3749-56. PubMed ID: 11238616
[TBL] [Abstract][Full Text] [Related]
14. Spectratyping analysis of the islet-reactive T cell repertoire in diabetic NOD Igμ(null) mice after polyclonal B cell reconstitution.
Vong AM; Daneshjou N; Norori PY; Sheng H; Braciak TA; Sercarz EE; Gabaglia CR
J Transl Med; 2011 Jul; 9():101. PubMed ID: 21722394
[TBL] [Abstract][Full Text] [Related]
15. Lipopolysaccharide-activated B cells down-regulate Th1 immunity and prevent autoimmune diabetes in nonobese diabetic mice.
Tian J; Zekzer D; Hanssen L; Lu Y; Olcott A; Kaufman DL
J Immunol; 2001 Jul; 167(2):1081-9. PubMed ID: 11441119
[TBL] [Abstract][Full Text] [Related]
16. Prevention of diabetes by FTY720-mediated stabilization of peri-islet tertiary lymphoid organs.
Penaranda C; Tang Q; Ruddle NH; Bluestone JA
Diabetes; 2010 Jun; 59(6):1461-8. PubMed ID: 20299465
[TBL] [Abstract][Full Text] [Related]
17. Granzyme B is dispensable in the development of diabetes in non-obese diabetic mice.
Mollah ZU; Graham KL; Krishnamurthy B; Trivedi P; Brodnicki TC; Trapani JA; Kay TW; Thomas HE
PLoS One; 2012; 7(7):e40357. PubMed ID: 22792290
[TBL] [Abstract][Full Text] [Related]
18. The healing myocardium mobilizes a distinct B-cell subset through a CXCL13-CXCR5-dependent mechanism.
Heinrichs M; Ashour D; Siegel J; Büchner L; Wedekind G; Heinze KG; Arampatzi P; Saliba AE; Cochain C; Hofmann U; Frantz S; Campos Ramos G
Cardiovasc Res; 2021 Nov; 117(13):2664-2676. PubMed ID: 34048536
[TBL] [Abstract][Full Text] [Related]
19. B lymphocyte depletion by CD20 monoclonal antibody prevents diabetes in nonobese diabetic mice despite isotype-specific differences in Fc gamma R effector functions.
Xiu Y; Wong CP; Bouaziz JD; Hamaguchi Y; Wang Y; Pop SM; Tisch RM; Tedder TF
J Immunol; 2008 Mar; 180(5):2863-75. PubMed ID: 18292508
[TBL] [Abstract][Full Text] [Related]
20. Pancreatic IL-4 expression results in islet-reactive Th2 cells that inhibit diabetogenic lymphocytes in the nonobese diabetic mouse.
Gallichan WS; Balasa B; Davies JD; Sarvetnick N
J Immunol; 1999 Aug; 163(3):1696-703. PubMed ID: 10415077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
